Kronos Bio CEO and Key Executive Team

• Norbert W. Bischofberger

  President, Chief Executive Officer and Director
• Arie Belldegrun

  Chairman
• Elena Ridloff

  Director
• Charles Lin

  Senior Vice President, Biology
• Wes Trotter

  Vice President, Chemistry
• Allison Frisbee

  Senior Vice President, Deputy General Counsel
• Douglas C. Saffran

  Vice President, Pharmacology
• Christopher Dinsmore

  Chief Scientific Officer
• Yasir Al-Wakeel

  Chief Financial Officer and Head of Corporate Development
• Barbara Kosacz

  Chief Operating Officer and General Counsel
• Kathryn Adamiak

  Vice President, Finance
• Richard Cutler

  Vice President, Clinical Science
• Rocio Martin Hoyos

  Vice President, Commercial Strategy
• Anders Vinther

  Vice President, Quality
• Marni Kottle

  Senior Vice President, Corporate Communications and Investor Relations
• Pavan Kumar

  Vice President, Translational Development
• Angela Koehler

  Scientific Advisory Board
• Jorge DiMartino

  Chief Medical Officer and Executive Vice President, Clinical Development
• Elizabeth Olek

  Senior Vice President, Clinical Development
• Matt Smith

  Vice President, U.S, Global Market Access and Reimbursement
• Zung To

  Vice President, Clinical Operations
• Roshawn Blunt

  Director
• Marianne De Backer

  Director
• Joshua Kazam

  Director
• Otello Stampacchia

  Director
• David Tanen

  Director
• Taiyin Yang

  Director

Source: kronosbio.com, kronosbio.com